HSBC Holdings’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-666,283
Closed -$66.2M 3303
2019
Q3
$66.2M Sell
666,283
-26,629
-4% -$2.53M 0.12% 159
2019
Q2
$64.1M Sell
692,912
-268,637
-28% -$25.5M 0.12% 157
2019
Q1
$90.7M Sell
961,549
-267,971
-22% -$23.4M 0.17% 125
2018
Q4
$78.8M Sell
1,229,520
-240,109
-16% -$17.7M 0.15% 138
2018
Q3
$132M Sell
1,469,629
-114,392
-7% -$10.1M 0.21% 86
2018
Q2
$126M Sell
1,584,021
-307,878
-16% -$25.6M 0.22% 77
2018
Q1
$169M Sell
1,891,899
-306,037
-14% -$29.4M 0.25% 68
2017
Q4
$229M Buy
2,197,936
+1,364,981
+164% +$154M 0.33% 64
2017
Q3
$121M Sell
832,955
-87,429
-9% -$11.9M 0.19% 93
2017
Q2
$120M Buy
920,384
+301,416
+49% +$36.9M 0.22% 76
2017
Q1
$77M Sell
618,968
-40,778
-6% -$4.88M 0.16% 111
2016
Q4
$76.4M Buy
659,746
+38,875
+6% +$4.33M 0.18% 120
2016
Q3
$64.7M Buy
620,871
+17,142
+3% +$1.86M 0.16% 131
2016
Q2
$59.6M Sell
603,729
-44,409
-7% -$4.59M 0.16% 144
2016
Q1
$64.8M Sell
648,138
-18,968
-3% -$1.95M 0.18% 123
2015
Q4
$80M Sell
667,106
-252,234
-27% -$29.2M 0.19% 103
2015
Q3
$99.2M Sell
919,340
-367,119
-29% -$45.6M 0.25% 86
2015
Q2
$149M Buy
1,286,459
+99,723
+8% +$11.4M 0.3% 70
2015
Q1
$137M Sell
1,186,736
-95,252
-7% -$11.4M 0.26% 75
2014
Q4
$144M Sell
1,281,988
-232,128
-15% -$24.5M 0.3% 67
2014
Q3
$144M Buy
1,514,116
+126,605
+9% +$11.4M 0.3% 71
2014
Q2
$119M Sell
1,387,511
-116,641
-8% -$8.87M 0.26% 87
2014
Q1
$105M Buy
1,504,152
+458,636
+44% +$36.3M 0.25% 85
2013
Q4
$88.3M Sell
1,045,516
-303,906
-23% -$24M 0.23% 88
2013
Q3
$104M Buy
1,349,422
+167,668
+14% +$11.8M 0.28% 72
2013
Q2
$69.2M Buy
+1,181,754
New +$71.1M 0.21% 98

Other funds holding CELG

HSBC Holdings's CELG Position: Q4 2019 in Review

HSBC Holdings sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 666,283 shares — an estimated $66.2M sold.

HSBC Holdings first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $229M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HSBC Holdings reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HSBC Holdings sold 666,283 Celgene Corp shares in Q4 2019, an estimated $66.2M.
  • HSBC Holdings first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • HSBC Holdings's Celgene Corp position peaked at $229M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HSBC Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.